These Drugmakers May Be Next to Make an M&A Splash in 2019

(Bloomberg) -- Biotechnology investors who eagerly waited for a much-hyped takeover boom in 2018 just got their gift of the new year -- Bristol-Myers Squibb Co. agreeing to buy Celgene Corp. for $7...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.